| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―May―18 |
Glycolytic Inhibition may not be a Pathway for Covid-19 Inhibition of 2-Deoxyglucose: Evidence from Computational Studies |
Pooventhiran Thangaiyan, Jesudoss Santhanasamy Kasparraj, Ali A Khairbek, Korada Rajashekaraiah Shadakshara Murthy, Renjith Thomas |
| 2 |
[GO] |
2026―Apr―30 |
Oligosaccharides as an Alternative Drug for COVID-19 - An In Silico Analysis |
Aanandhalakshmi Raghuraman, Gowtham Palani Shanthi, Bazeera Ferdhous Proskhan, Vanavil Balakrishnan |
| 3 |
[GO] |
2025―Jan―11 |
Identification of Natural Inhibitors of SARS-CoV-2 Main Protease (Mpro) via Structure-Based Virtual Screening and Molecular Dynamics Simulations |
|
| 4 |
[GO] |
2025―Jan―11 |
Computational Investigation on the Physiochemical, Structural, and Binding Features of BA.2.75 and BA.2.75.2 Omicron Variants of SARS-CoV-2 |
|
| 5 |
[GO] |
2025―Jan―11 |
Interactions of ED Compound with some Spike Protein Variants of SARS-CoV-2 |
|
| 6 |
[GO] |
2025―Jan―11 |
Relationship Between Occurrence of Neurological Disorders and Coronavirus Infection via Protein-Protein Sequence Matching Analysis Technique and Repurposing Neuroprotective Agents in the Treatment of Coronavirus Infection |
|
| 7 |
[GO] |
2025―Jan―11 |
Novel M-Polynomials for Computing Graph Invariants of Certain Drugs: Targeting COVID-19 and Omicron |
|
| 8 |
[GO] |
2025―Jan―10 |
In silico Identification of Natural Chromones against SARS-CoV-2 Mpro and Mutated Spike RBDs. Molecular Docking, Dynamics Simulations, and Pharmacokinetic Prediction |
|
| 9 |
[GO] |
2025―Jan―10 |
Computational Investigation on the Impact of Mutations in the SARS-CoV-2 Spike RBD Region of BA.2.12.1 and BA.4 Variants on its Interaction with ACE2 Receptor Protein |
|
| 10 |
[GO] |
2025―Jan―10 |
Recent Developments in the Antiviral Activity of Glycyrrhizic Acid and its Derivatives Against SARS-CoV-2: Computational Aspects |
|
| 11 |
[GO] |
2022―Nov―07 |
Infectivity, Morbidity, Emerged Variants of SARS-CoV-2 and Vaccination in Indian Perspectives from First Wave to Second Wave of COVID-19 |
|
| 12 |
[GO] |
2022―Nov―07 |
Pharmacotherapeutic and Computational Approaches for Biopharmaceutical Considerations towards Drug Development and Delivery against COVID-19 |
|
| 13 |
[GO] |
2022―Nov―07 |
Herbal Immunomodulators: A Powerful Preventive Weapon for COVID-19 |
|
| 14 |
[GO] |
2022―Nov―07 |
Molecular Docking and Dynamic Simulation Studies of Cu(II) Metal Complexes with Covid-19 main Protease |
|
| 15 |
[GO] |
2022―Nov―07 |
Could Molnupiravir Have an Ameliorative Effect in Pets with COVID-19? |
|
| 16 |
[GO] |
2022―Nov―07 |
Comprehensive In silico Investigation Validates Two Flavonoid Compounds of Derris robusta (Roxb. ex DC.) Benth. to Supplant Remdesivir as Natural Therapeutic Remedy Against a Range of Coronaviruses |
|
| 17 |
[GO] |
2022―Nov―07 |
Effect of Mutations in the SARS-CoV-2 Spike RBD Region of Delta and Delta-Plus Variants on its Interaction with ACE2 Receptor Protein |
|
| 18 |
[GO] |
2022―Apr―10 |
A Bibliometric Analysis of Moderna mRNA-1273 Vaccine for COVID-19 |
|
| 19 |
[GO] |
2022―Apr―10 |
Cerium Oxide (CeO2) Nanoparticles Could Have Protective Effect Against COVID-19 |
|
| 20 |
[GO] |
2022―Apr―10 |
Teriflunomide and COVID-19: A Friend or Foe?! |
|
| 21 |
[GO] |
2022―Apr―10 |
Diagnostic Approaches for Covid-19: Present Status and Future Prospects |
|
| 22 |
[GO] |
2022―Apr―10 |
Identification of Synthetic 2-Mercaptobenzimidazole Derivatives as Inhibitors of Spike Protein of SARS-CoV-2 by Virtual Screening |
|
| 23 |
[GO] |
2021―Dec―29 |
Novel Corona Virus (COVID-19): Current Strategies and Future Aspects |
|
| 24 |
[GO] |
2021―Dec―29 |
Therapeutic Index of Herbal Medicine in Pandemic COVID-19: A Review |
|
| 25 |
[GO] |
2021―Dec―29 |
Identification of a Plausible Inhibitor of SARS-Cov 2 Protease (6LU7) and the Spike Envelope Glycoprotein (6MOJ) from Active Compounds of Nigella sativa: An In-silico Approach |
|
| 26 |
[GO] |
2021―Oct―31 |
Mucormycosis-a Fungal Infection in Patient Recovered from COVID-19 |
|
| 27 |
[GO] |
2021―Oct―31 |
The Diagnostics Technologies and Control of COVID-19 |
|
| 28 |
[GO] |
2021―Oct―31 |
At the Crossroads of One Health: Lessons Learned from Foot and Mouth Disease in COVID-19 Pandemic |
|
| 29 |
[GO] |
2021―Oct―31 |
Virtual Screening of Potential Drug Molecules Against Covid-19 Targets: A Drug Repurposing Approach |
|
| 30 |
[GO] |
2021―Oct―31 |
COVID-19 Vaccine, Contraceptive, Viscosity and Safety Margin Change |
|
| 31 |
[GO] |
2021―May―09 |
Overview of Spray Aerosols for Disinfection Against Airborne and Surface Spread of Covid-19 |
|
| 32 |
[GO] |
2021―May―09 |
Correlation of CoViD-19 Infection and Tumorigenesis |
|
| 33 |
[GO] |
2021―May―09 |
An Insight into Ayurveda and Yogic Practices Sustain Physical and Mental Health in COVID-19 Pandemic |
|
| 34 |
[GO] |
2021―May―09 |
Molecular Insights of Immune Responses Variability in COVID-19 Patients: A Review |
|
| 35 |
[GO] |
2021―May―09 |
Forecasting COVID-19 Transmission in India Using Deep Learning Models |
|
| 36 |
[GO] |
2021―May―09 |
Nanotechnology in Battle against CoViD-19: The Prevention, Diagnosis, and Treatment |
|
| 37 |
[GO] |
2021―May―09 |
Novel Coronavirus (2019-nCoV) pandemic: How Far or How Close is the Solution? |
|
| 38 |
[GO] |
2021―May―09 |
A Computational Approach on the Activity of Hesperidin as Antagonist for Proteins of SARS-CoV-2 |
|
| 39 |
[GO] |
2021―May―09 |
Repurposing of Anthelmintic Drugs against SARS-CoV-2 (Mpro and RdRp): Novel Disease, Older Therapeutics |
|
| 40 |
[GO] |
2021―May―09 |
Impact of COVID 19 Pandemic Crisis on the Health System and Pharmaceutical Industry |
|
| 41 |
[GO] |
2020―Oct―07 |
A Review on Hydroxychloroquine Drug: to Combat COVID-19 |
|
| 42 |
[GO] |
2020―Oct―07 |
Recent Updates in the Pharmacological Management of COVID-19 |
|
| 43 |
[GO] |
2020―Oct―07 |
Food Security, Safety, and Nutritional Concerns during a COVID-19 Pandemic: the Global Challenges |
|
| 44 |
[GO] |
2020―Oct―07 |
Nanodiagnosis for Diagnosing COVID-19: a Brief Review |
|
| 45 |
[GO] |
2020―Oct―07 |
Curcuma longa Aided Ag/CS Nanocomposite Coating of Surfaces as SARS-CoV-2 Contamination Minimizing Measure Towards Containment of COVID-19: a Perspective |
|
| 46 |
[GO] |
2020―Oct―07 |
Air Quality During COVID-19: Analysis of Particulate Matter for a Coastal Urban Station Visakhapatnam(India) |
|
| 47 |
[GO] |
2020―Oct―07 |
A Review on Medicinal Plants Withania somnifera and Nyctanthes arbortristis: Boosting of Immune System During SARS-CoV-2 |
|
| 48 |
[GO] |
2020―Oct―07 |
Outbreak, Prevalence and Mortality of Severe Acute Respiratory Syndrome (SARS-CoV-2) Infections in Kerala- A Perspective Study |
|
| 49 |
[GO] |
2020―Oct―07 |
Mutation Prone Point Within Spike Protein Molecule of SARS-CoV2: A Nanoinformatics Study |
|
| 50 |
[GO] |
2020―Aug―03 |
Design and Synthesis of Five Cyclobuta-1,3-Dien-1-yl-Steroid Derivatives to Evaluate Their Theoretical Activity Against COVID-19 |
|
| 51 |
[GO] |
2020―Aug―03 |
Molecular Docking Study on Some Isonicotinoyl Hydrazide Derivatives as Potential Inhibitors of COVID-19 |
|
| 52 |
[GO] |
2020―Aug―03 |
An Epidemiological Characteristic of the COVID-19 Among Children |
|
| 53 |
[GO] |
2020―Aug―03 |
Highlights on Evidence-Based Treatment Strategies for COVID-19: a Review |
|
| 54 |
[GO] |
2020―Aug―03 |
COVID-19: Socioeconomic, Environmental, Psychological Effects, and Prediction Models |
|
